You just read:

aTyr Pharma Receives U.S. FDA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris™

News provided by

aTyr Pharma, Inc.

Feb 28, 2017, 08:00 ET